Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,950,119
-
Total 13F shares
-
57,796,599
-
Share change
-
+1,100,774
-
Total reported value
-
$3,141,458,935
-
Put/Call ratio
-
643%
-
Price per share
-
$54.35
-
Number of holders
-
216
-
Value change
-
+$63,997,259
-
Number of buys
-
104
-
Number of sells
-
83
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2019
As of 31 Mar 2019,
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) was held by
216 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,796,599 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, HILLHOUSE CAPITAL ADVISORS, LTD., FIRST TRUST ADVISORS LP, JPMORGAN CHASE & CO, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
217
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.